Press release
Malignant Ascites Market Growth to Accelerate in Forecast Period (2024-2034) | estimates DelveInsight
Malignant Ascites Drugs Market
Discover Key Insights into the Malignant Ascites Market with DelveInsight's In-Depth Report @ Malignant Ascites Market Size- https://www.delveinsight.com/sample-request/malignant-ascites-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Key Takeaways from the Malignant Ascites Market Report
• Among the 7MM, the United States accounted for the highest incident cases of Malignant ascites in 2020, with around 350,000 cases; these cases are expected to increase during the forecast period.
• Among all the associated cancers, the highest incident cases were reported in Breast Cancer. In 2020 the total incident cases of Breast Cancer were 640,000.
• In 2020, the total patient pool of Malignant Ascites were 390,000 in the EU4 and the UK.
• The leading Malignant Ascites Companies such as Clover Biopharmaceuticals, Wuhan YZY Biopharma Co., Ltd., Neovii Biotech, Jiangsu Simcere Pharmaceutical, Neovii Biotech, Sanofi, and others
• Promising Malignant Ascites Therapies such as SCB-313, M701, catumaxomab, Endostar, Catumaxomab, aflibercept (ziv-aflibercept, AVE0005, VEGF trap, ZALTRAP®), and others
Navigate the complexities of the Malignant Ascites Market: gain insights into drug trends, treatment scenarios, and epidemiological data through our insightful Malignant Ascites Market Forecast. Click here to get more insights @ Malignant Ascites Treatment Market- https://www.delveinsight.com/sample-request/malignant-ascites-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Malignant Ascites Epidemiology Segmentation in the 7MM
• Total Incident Cases of Ascites in Selected Indications (Ovarian, Colorectal, Gastric, and Others) in the 7MM
• Incident Cases of Malignant Ascites in Selected Indications in the 7MM
• Total Treated Cases of Malignant Ascites in the 7MM
Download the report to understand which factors are driving Malignant Ascites epidemiology trends @ Malignant Ascites Prevalence- https://www.delveinsight.com/sample-request/malignant-ascites-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Malignant ascites Emerging Drugs Profile
• Catumaxomab: Lindis Biotech
Catumaxomab is a bispecific trifunctional antibody that binds directly to the tumor cell with one of its binding sites. It activates two essential components of the immune system with the other binding sites: T cells and macrophages (scavenger cells). The antibody recognizes and binds to all EpCAM-positive tumor cells, including critical cancer stem cells and all CD3-positive T cells. The EpCAM marker is present on almost all carcinomas and is, therefore, a promising approach for targeted cancer treatment. As per company pipeline, catumaxomab is in the preregistration stage of development for the treatment of Malignant ascites.
• M 701: Wuhan YZY Biopharma
M701 is a new biological Class I drug that targets both EpCAM and CD3 being developed by YBODY Biotech through its independently patented asymmetric bispecific antibody YBODY® platform. The drug is mainly used for the treatment of malignant ascites (MA) and malignant pleural effusion (MPE) derived from EpCAM-positive cancer.M701 dual-antibody targets the EpCAM antigen on one end. At the same time, the CD3 antibody on the other end can bridge T cells and activate T cells to kill EpCAM-positive tumor cells. Currently, M701 is in the Phase II stage of development for the treatment of malignant ascites.
Malignant Ascites Drugs Market Insights
Antibody-dependent cell cytotoxicity
Antibody-Dependent Cellular Cytotoxicity (ADCC) is a crucial mechanism of the immune system involving the targeting and destruction of pathogenic cells by effector cells, particularly natural killer (NK) cells. ADCC is a process where specific antibodies bind to pathogens, marking them for destruction by NK cells through the injection of cytotoxic factors, leading to cell lysis. Antibodies recognize and bind to target cells, which are then attacked and destroyed by effector cells like NK cells. This process plays a vital role in immune responses against pathogens and cancer cells.
Get In-Depth Knowledge on Malignant Ascites Market Trends and Forecasts with DelveInsight @ Malignant Ascites Treatment Market- https://www.delveinsight.com/sample-request/malignant-ascites-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Malignant Ascites Therapies and Companies
• SCB-313: Clover Biopharmaceuticals
• M701: Wuhan YZY Biopharma Co., Ltd.
• catumaxomab: Neovii Biotech
• Endostar: Jiangsu Simcere Pharmaceutical
• Catumaxomab: Neovii Biotech
• aflibercept (ziv-aflibercept, AVE0005, VEGF trap, ZALTRAP®): Sanofi
Scope of the Malignant Ascites Market Report
• Study Period: 2020-2034
• Coverage: 7MM
• Malignant Ascites Companies: Clover Biopharmaceuticals, Wuhan YZY Biopharma Co., Ltd., Neovii Biotech, Jiangsu Simcere Pharmaceutical, Neovii Biotech, Sanofi, and others
• Malignant Ascites Therapies: SCB-313, M701, catumaxomab, Endostar, Catumaxomab, aflibercept (ziv-aflibercept, AVE0005, VEGF trap, ZALTRAP®), and others
• Malignant Ascites Therapeutic Assessment: Malignant Ascites current marketed and Malignant Ascites emerging therapies
• Malignant Ascites Market Dynamics: Malignant Ascites market drivers and Malignant Ascites market barriers
• Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
• Malignant Ascites Unmet Needs, KOL's views, Analyst's views, Malignant Ascites Market Access and Reimbursement
Gain a strategic edge in the Malignant Ascites Market: explore comprehensive drug insights, treatment updates, and epidemiological forecasts in our in-depth Malignant Ascites Market Forecast. Click here to lead in advancements @ Malignant Ascites Clinical Trials Assessment- https://www.delveinsight.com/sample-request/malignant-ascites-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Table of Contents
1. Malignant Ascites Market Report Introduction
2. Executive Summary for Malignant Ascites
3. SWOT analysis of Malignant Ascites
4. Malignant Ascites Patient Share (%) Overview at a Glance
5. Malignant Ascites Market Overview at a Glance
6. Malignant Ascites Disease Background and Overview
7. Malignant Ascites Epidemiology and Patient Population
8. Country-Specific Patient Population of Malignant Ascites
9. Malignant Ascites Current Treatment and Medical Practices
10. Malignant Ascites Unmet Needs
11. Malignant Ascites Emerging Therapies
12. Malignant Ascites Market Outlook
13. Country-Wise Malignant Ascites Market Analysis (2020-2034)
14. Malignant Ascites Market Access and Reimbursement of Therapies
15. Malignant Ascites Market Drivers
16. Malignant Ascites Market Barriers
17. Malignant Ascites Appendix
18. Malignant Ascites Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
List of Top Selling Market Research Reports in 2025
Surgical Lasers Market - https://www.delveinsight.com/report-store/surgical-lasers-market
Intraocular Lens Market - https://www.delveinsight.com/blog/top-companies-in-the-intraocular-lens-market
Myeloproliferative Neoplasms Market - https://www.delveinsight.com/report-store/myeloproliferative-neoplasms-market
Skin Neoplasm Market - https://www.delveinsight.com/report-store/nonmelanoma-skin-cancer-market
Healthcare Competitive Benchmarking - https://www.delveinsight.com/consulting/competitive-benchmarking-services
Microscopy Device Market - https://www.delveinsight.com/report-store/microscopy-device-market
Pacemakers Market - https://www.delveinsight.com/report-store/pacemakers-market
Urea Cycle Disorders Market - https://www.delveinsight.com/blog/urea-cycle-disorder-market
Novel Drug Delivery Devices Market - https://www.delveinsight.com/report-store/novel-drug-delivery-devices
Nk Cell Therapy Market - https://www.delveinsight.com/infographics/nk-cell-therapy-market
Surgical Mask & Respirator Market - https://www.delveinsight.com/report-store/surgical-mask-respirator-market
Lymphoedema Market - https://www.delveinsight.com/report-store/lymphoedema-market
Phototherapies For Psoriasis Market - https://www.delveinsight.com/report-store/phototherapy-devices-market
Sepsis Market - https://www.delveinsight.com/report-store/sepsis-market
Bone Growth Stimulator Market - https://www.delveinsight.com/report-store/bone-growth-stimulators-market
Antibody Drug Conjugate Market - https://www.delveinsight.com/report-store/antibody-drug-conjugate-market
Overactive Bladder Syndrome Market - https://www.delveinsight.com/report-store/underactive-bladder-market
Medical Marijuana Market - https://www.delveinsight.com/report-store/medical-marijuana-market
Lactose Intolerance Market - https://www.delveinsight.com/report-store/lactose-intolerance-market
Catheter Stabilization Devices Market - https://www.delveinsight.com/sample-request/catheter-stabilization-securement-device-market
Dyspepsia Market - https://www.delveinsight.com/report-store/functional-dyspepsia-pipeline-insight
Total Knee Arthroplasty Market - https://www.delveinsight.com/report-store/knee-reconstruction-devices-market
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: ybhardwaj@delveinsight.com
Phone: 9650213330
Address: 304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Malignant Ascites Market Growth to Accelerate in Forecast Period (2024-2034) | estimates DelveInsight here
News-ID: 3847045 • Views: …
More Releases from DelveInsight Business Research LLP
Genital Warts Pipeline Insights Report 2025 | DelveInsight
DelveInsight's, "Genital Warts Pipeline Insight 2025" report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Genital Warts pipeline landscape. It covers the Genital Warts pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight and stay ahead…
Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
DelveInsight's "Traumatic Brain Injury Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Tthe raumatic Brain Injury pipeline landscape. It covers the Traumatic Brain Injury pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Traumatic Brain Injury pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore…
Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
DelveInsight's, "Bone Metastases Pipeline Insight, 2025," report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Bone Metastases pipeline landscape. It covers the Bone Metastasis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Bone Metastasis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight…
Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsi …
DelveInsight's "Acquired Immunodeficiency Syndrome Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Acquired Immunodeficiency Syndrome, historical and forecasted epidemiology as well as the Acquired Immunodeficiency Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
To Know in detail about the Acquired Immunodeficiency Syndrome market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Acquired Immunodeficiency Syndrome Market…
More Releases for Malignant
Malignant Mesothelioma Market Size and Forecast
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- The global Malignant Mesothelioma Market is expected to record a CAGR of XX.X% from 2024 to 2031 In 2024, the market size is projected to reach a valuation of USD XX.X Billion. By 2031 the valuation is anticipated to reach USD XX.X Billion.
The impact of manufacturers on the market is significant across various industries, influencing supply chains, consumer choices, and economic growth. Manufacturers are key players in…
Adult Malignant Glioma Therapeutics Market - Defying the Tumor, Empowering Survi …
Newark, New Castle, USA - new report, titled Adult Malignant Glioma Therapeutics Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Adult Malignant Glioma Therapeutics market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Adult Malignant Glioma Therapeutics market. The report offers…
Malignant Mesothelioma-Pipeline Review H2 2018
Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Human Parainfluenza Virus 3 Infections-Pipeline Review, H2 2018, provides an overview of the Human Parainfluenza Virus 3 Infections (Infectious Disease) pipeline landscape.
Human parainfluenza virus 3 is a life-threatening infection that causes respiratory illnesses in infants and young children. Symptoms include fever, cough, runny nose, croup, bronchiolitis, wheezing and sore throat. Treatment includes over-the-counter medications for pain and fever.
Report Highlights
Publisher's Pharmaceutical…
Malignant Mesothelioma-Pipeline Review H2 2018
Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Malignant Mesothelioma-Pipeline Review, H2 2018, provides an overview of the Malignant Mesothelioma (Oncology) pipeline landscape.
Malignant pleural mesothelioma is a rare cancer often diagnosed in people who have been exposed to high levels of asbestos. The malignancy affects the pleura, a thin membrane of lubricating cells that lines the lungs and chest wall. Peritoneal mesothelioma originates in the abdomen and as a result,…
Malignant Melanoma Drug Market Malignant Melanoma Clinical Pipeline Report
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Malignant Melanoma
2. Malignant Melanoma Drug Mechanism of Action
3. Global Malignant Melanoma Market Analysis
3.1 Current Market Scenario
3.2 Global Malignant Melanoma Pipeline Overview
4. Global Malignant Melanoma Drug Market Dynamics
4.1 Favorable Market Parameters
4.2 Commercialization Challenges
5. Global Malignant Melanoma Drug Market Future Prospects
6. Global Malignant Melanoma Clinical Pipeline By…
Rising Number of People Diagnosed with Malignant Glioma Supports the Growth of t …
Glioma is a type of tumor that occurs in brain or spine. It is a group of brain tumor that includes oligodendrogliomas and astrocytomas. Gliomas include all types of brain tumors arising from supportive tissue of the brain. Malignant glioma is the most common type of brain tumor observed in adults globally. Collectively they contribute around 40% of the total cases diagnosed with brain tumor. In the last decade, there…
